Personalized guidance for advanced cancer
Cancer Commons (cancercommons.org) earns a Brand Analyzer score of 75 out of 100, placing it in the Brand-Ready tier among Healthcare brands, Non-profit brands. Among 4481 Healthcare brands analyzed, Cancer Commons ranks in the 55th percentile (category average 74, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 83/100, Digital Presence 100/100, Visual Identity 97/100, Messaging Clarity 100/100, Trust Foundation 83/100, AI Discoverability 72/100, Brand Authority 16/100.
Cancer Commons is a nonprofit organization that provides personalized, precision treatment guidance to advanced cancer patients. It connects patients with treatment matching, clinical trial options, and strategic care planning, drawing on experience that has helped over 10,000 patients. The organization positions itself as a trusted resource bridging patients with cutting-edge cancer research and clinical trials beyond standard care, aiming to optimize individual patient outcomes through tailored guidance.
| Brand Name | Cancer Commons |
|---|---|
| Domain | cancercommons.org |
| Industry | Healthcare, Non-profit |
| Main Competitors | Perthera (76/100), Massive Bio (81/100), Antidote (81/100), My Cancer Genome, CancerCare |
Moz Domain Authority 45/100 vs category average 37 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Personalized cancer guidance for advanced cancer patients. 10,000+ patients helped with precision treatment matching, clinical trials, and strategic planning." (Meta description: 19 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Webflow.
Social footprint: verified profiles on YouTube, LinkedIn, X (Twitter), Instagram, GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Cancer Commons scores 22/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Cancer Commons has a weak AI-visibility profile at 22/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (58/100) and its weakest is visibility (0/100). It benefits from a Moz Domain Authority of 45/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and thin schema.org structured data. In a live check, Claude could already identify Cancer Commons from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Cancer Commons?", Claude could identify the brand as of August 2026. Cancer Commons is a nonprofit organization that helps cancer patients identify personalized treatment options by connecting them with a network of scientists and clinicians who analyze their specific case, especially for those who have run out of standard treatment options. Best known for Providing free personalized treatment guidance and matching cancer patients to clinical trials and off-label therapy options.
When asked "Best brands similar to Cancer Commons?", Claude would recommend Cancer Commons as of August 2026. It's a well known nonprofit in the precision oncology and patient advocacy space, so it would come up naturally when discussing resources for personalized cancer treatment guidance.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Cancer Commons's main competitors include Perthera, Massive Bio (81/100), Antidote (81/100), My Cancer Genome, CancerCare. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Cancer Commons and Massive Bio are competitors in Healthcare. Brand Analyzer scores Cancer Commons at 75/100 and Massive Bio at 81/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Cancer Commons include Perthera, Massive Bio (81/100), Antidote (81/100), My Cancer Genome, CancerCare. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Cancer Commons has low AI-search visibility, scoring 22/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 26, recommendation 58). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Cancer Commons official site
Cancer Commons offers services including personalized precision treatment matching, identification and access to relevant clinical trials, and strategic care planning for advanced cancer patients. These services are designed to help patients find treatment options tailored to their specific cancer type and situation, going beyond standard-of-care approaches.
Sources: Cancer Commons official site
Cancer Commons scores 58/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Cancer Commons official site
Cancer Commons is a nonprofit organization that offers personalized, precision treatment guidance to advanced cancer patients. It focuses on connecting patients with treatment matching, clinical trial opportunities, and strategic care planning based on their specific cancer type and molecular profile. The organization has reportedly helped more than 10,000 patients navigate complex treatment decisions beyond standard-of-care options.
Sources: Cancer Commons official site
Cancer Commons provides personalized cancer guidance services for advanced cancer patients, including precision treatment matching, identification of relevant clinical trials, and strategic care planning. It works to connect patients with cutting-edge research and treatment options that may not be part of conventional care pathways, aiming to optimize each patient's individual outcome.
Sources: Cancer Commons official site
Cancer Commons can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Cancer Commons official site
Cancer Commons is used by advanced cancer patients and their families who are seeking personalized treatment options, access to clinical trials, and strategic guidance beyond conventional cancer care. The organization has reportedly served more than 10,000 such patients.
Sources: Cancer Commons official site
Cancer Commons is known for helping advanced cancer patients find personalized, precision treatment options and clinical trials beyond standard care. It has reportedly assisted over 10,000 patients with treatment matching and strategic care planning as a nonprofit organization.
Sources: Cancer Commons official site
Ranked closest to Cancer Commons: Cal-a-Vie Health Spa (75/100), BrainKey (75/100), CareATC (75/100), CareEvolution (75/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), Zimmer Biomet (81/100).
Category leader: Elsevier (96/100).